 |
PDBsum entry 4gg8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4gg8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Immune receptor
|
|
Structure:
|
 |
T-cell receptor, sp3.4 alpha chain. Chain: e, a. Fragment: extracellular domains. Engineered: yes. Mutation: yes. T-cell receptor, sp3.4 beta chain. Chain: f, b. Fragment: extracellular domains. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
3.20Å
|
R-factor:
|
0.265
|
R-free:
|
0.308
|
|
|
Authors:
|
 |
S.E.Broughton,A.Theodossis,J.Petersen,H.H.Reid,J.Rossjohn
|
|
Key ref:
|
 |
S.E.Broughton
et al.
(2012).
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease.
Immunity,
37,
611-621.
PubMed id:
|
 |
|
Date:
|
 |
|
06-Aug-12
|
Release date:
|
24-Oct-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Immunity
37:611-621
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease.
|
|
S.E.Broughton,
J.Petersen,
A.Theodossis,
S.W.Scally,
K.L.Loh,
A.Thompson,
J.van Bergen,
Y.Kooy-Winkelaar,
K.N.Henderson,
T.Beddoe,
J.A.Tye-Din,
S.I.Mannering,
A.W.Purcell,
J.McCluskey,
R.P.Anderson,
F.Koning,
H.H.Reid,
J.Rossjohn.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Celiac disease is a human leukocyte antigen (HLA)-DQ2- and/or DQ8-associated
T cell-mediated disorder that is induced by dietary gluten. Although it is
established how gluten peptides bind HLA-DQ8 and HLA-DQ2, it is unclear how
such peptide-HLA complexes are engaged by the T cell receptor (TCR), a
recognition event that triggers disease pathology. We show that biased TCR
usage (TRBV9(∗)01) underpins the recognition of HLA-DQ8-α-I-gliadin. The
structure of a prototypical TRBV9(∗)01-TCR-HLA-DQ8-α-I-gliadin complex shows
that the TCR docks centrally above HLA-DQ8-α-I-gliadin, in which all
complementarity-determining region-β (CDRβ) loops interact with the gliadin
peptide. Mutagenesis at the TRBV9(∗)01-TCR-HLA-DQ8-α-I-gliadin interface
provides an energetic basis for the Vβ bias. Moreover, CDR3 diversity accounts
for TRBV9(∗)01(+) TCRs exhibiting differing reactivities toward the gliadin
epitopes at various deamidation states. Accordingly, biased TCR usage is an
important factor in the pathogenesis of DQ8-mediated celiac disease.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|